p.100 抽出テキスト

placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med 2015;13:78. https://doi.org/10.1186/s12916-015-0328-1 699. Todd OM, Wilkinson C, Hale M, Wong NL, Hall M, Sheppard JP, et al. Is the association between blood pressure and mortality in older adults different with frailty? A systematic review and meta-analysis. Age Ageing 2019;48:627–35. https://doi.org/10.1093/ ageing/afz072 700. Li Y, Thijs L, Zhang ZY, Asayama K, Hansen TW, Boggia J, et al. Opposing age-related trends in absolute and relative risk of adverse health outcomes associated with out-of-office blood pressure. Hypertension 2019;74:1333–42. https://doi.org/10. 1161/hypertensionaha.119.12958 701. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887–98. https://doi.org/10.1056/NEJMoa0801369 702. Peters R, Beckett N, McCormack T, Fagard R, Fletcher A, Bulpitt C. Treating hypertension in the very elderly-benefits, risks, and future directions, a focus on the hypertension in the very elderly trial. Eur Heart J 2014;35:1712–8. https://doi.org/10.1093/eurheartj/eht464 703. Travers J, Romero-Ortuno R, Bailey J, Cooney MT. Delaying and reversing frailty: a systematic review of primary care interventions. Br J Gen Pract 2019;69:e61–9. https://doi. org/10.3399/bjgp18X700241 704. Bogaerts JMK, von Ballmoos LM, Achterberg WP, Gussekloo J, Streit S, van der Ploeg MA, et al. Do we AGREE on the targets of antihypertensive drug treatment in older adults: a systematic review of guidelines on primary prevention of cardiovascular diseases. Age Ageing 2022;51:afab192. https://doi.org/10.1093/ageing/afab192 705. Sheppard JP, Benetos A, McManus RJ. Antihypertensive deprescribing in older adults: a practical guide. Curr Hypertens Rep 2022;24:571–80. https://doi.org/10.1007/s11906- 022-01215-3 706. McDonnell CC, Rogers KC, Regen SM, Finks SW. The Fall Risk with Alpha blockers Given InitiaL dose or Elderly status (FRAGILE) study. Ann Pharmacother 2020;54: 226–31. https://doi.org/10.1177/1060028019880305 707. Hiremath S, Ruzicka M, Petrcich W, McCallum MK, Hundemer GL, Tanuseputro P, et al. Alpha-blocker use and the risk of hypotension and hypotension-related clinical events in women of advanced age. Hypertension 2019;74:645–51. https://doi.org/10. 1161/hypertensionaha.119.13289 708. Li H, Xu TY, Li Y, Chia Y-C, Buranakitjaroen P, Cheng H-M, et al. Role of α1-blockers in the current management of hypertension. J Clin Hypertens (Greenwich) 2022;24: 1180–6. https://doi.org/10.1111/jch.14556 709. Ravindrarajah R, Dregan A, Hazra NC, Hamada S, Jackson SHD, Gulliford MC, et al. Declining blood pressure and intensification of blood pressure management among people over 80 years: cohort study using electronic health records. J Hypertens 2017;35:1276–82. https://doi.org/10.1097/hjh.0000000000001291 710. Chun S, Han K, Lee S, Cho M-H, Jeong S-M, Jung H-W, et al. Impact of frailty on the relationship between blood pressure and cardiovascular diseases and mortality in young-old adults. J Pers Med 2022;12:418. https://doi.org/10.3390/jpm12030418 711. Khan N, McAlister FA. Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ 2006;174:1737–42. https://doi.org/10.1503/cmaj. 060110 712. Lavan AH, Gallagher P, Parsons C, O’Mahony D. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing 2017;46:600–7. https://doi.org/10.1093/ageing/afx005 713. Eeftinck Schattenkerk DW, van Gorp J, Vogt L, Peters RJ, van den Born BH. Isolated systolic hypertension of the young and its association with central blood pressure in a large multi-ethnic population. The HELIUS study. Eur J Prev Cardiol 2018;25: 1351–9. https://doi.org/10.1177/2047487318777430 714. Franklin SS, Jacobs MJ, Wong ND, L’Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001;37:869–74. https://doi.org/10.1161/01.hyp.37.3.869 715. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012;30:445–8. https://doi. org/10.1097/HJH.0b013e32834fa8b0 716. The Reference Values for Arterial Stiffness Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J 2010;31:2338–50. https://doi.org/10. 1093/eurheartj/ehq165 717. Li Y, Wei FF, Thijs L, Boggia J, Asayama K, Hansen TW, et al. Ambulatory hypertension subtypes and 24-hour systolic and diastolic blood pressure as distinct outcome predictors in 8341 untreated people recruited from 12 populations. Circulation 2014;130: 466–74. https://doi.org/10.1161/circulationaha.113.004876 718. Staessen JA, Gasowski J, Wang JG, Thijs L, Hond ED, Boissel J-P, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000;355:865–72. https://doi.org/10.1016/s0140-6736(99)07330-4 719. McEniery CM, Yasmin, Wallace S, Maki-Petaja K, McDonnell B, Sharman JE, et al. Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults. Hypertension 2005;46:221–6. https://doi.org/10.1161/01.HYP. 0000165310.84801.e0 720. Palatini P, Rosei EA, Avolio A, Bilo G, Casiglia E, Ghiadoni L, et al. Isolated systolic hypertension in the young: a position paper endorsed by the European Society of Hypertension. J Hypertens 2018;36:1222–36. https://doi.org/10.1097/hjh. 0000000000001726 721. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension 2020;75:1334–57. https://doi.org/10.1161/hypertensionaha.120.15026 722. Yano Y, Chang Kim H, Lee H, Azahar N, Ahmed S, Kitaoka K, et al. Response to isolated diastolic hypertension and risk of cardiovascular disease: controversies in hypertension—con side of the argument. Hypertension 2022;79:1579. https://doi.org/10. 1161/hypertensionaha.122.19493 723. Jacobsen AP, McKittrick M, Daya N, Al Rifai M, McEvoy JW. Isolated diastolic hypertension and risk of cardiovascular disease: controversies in hypertension— con side of the argument. Hypertension 2022;79:1571–8. https://doi.org/10.1161/ hypertensionaha.122.18458 724. Blank SG, Mann SJ, James GD, West JE, Pickering TG. Isolated elevation of diastolic blood pressure. Real or artifactual? Hypertension 1995;26:383–9. https://doi.org/10. 1161/01.hyp.26.3.383 725. Cho SMJ, Lee H, Koyama S, Zou RS, Schuermans A, Ganesh S, et al. Cumulative diastolic blood pressure burden in normal systolic blood pressure and cardiovascular disease. Hypertension 2024;81:273–81. https://doi.org/10.1161/hypertensionaha. 123.22160 726. Grobman B, Turkson-Ocran RN, Staessen JA, Yu Y-L, Lipsitz LA, Mukamal KJ, et al. Body position and orthostatic hypotension in hypertensive adults: results from the Syst-Eur trial. Hypertension 2023;80:820–7. https://doi.org/10.1161/hypertensionaha. 122.20602 727. Juraschek SP, Taylor AA, Wright JT Jr, Evans GW, Miller ER, Plante TB, et al. Orthostatic hypotension, cardiovascular outcomes, and adverse events: results from SPRINT. Hypertension 2020;75:660–7. https://doi.org/10.1161/hypertensionaha. 119.14309 728. Juraschek SP, Daya N, Appel LJ, Miller ER, McEvoy JW, Matsushita K, et al. Orthostatic hypotension and risk of clinical and subclinical cardiovascular disease in middle-aged adults. J Am Heart Assoc 2018;7:e008884. https://doi.org/10.1161/jaha.118.008884 729. Fleg JL, Evans GW, Margolis KL, Barzilay J, Basile JN, Bigger JT, et al. Orthostatic hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) blood pressure trial: prevalence, incidence, and prognostic significance. Hypertension 2016; 68:888–95. https://doi.org/10.1161/hypertensionaha.116.07474 730. Juraschek SP, Hu JR, Cluett JL, Ishak A, Mita C, Lipsitz LA, et al. Effects of intensive blood pressure treatment on orthostatic hypotension : a systematic review and individual participant-based meta-analysis. Ann Intern Med 2021;174:58–68. https://doi. org/10.7326/m20-4298 731. Ylitalo A, Airaksinen KE, Sellin L, Huikuri HV. Effects of combination antihypertensive therapy on baroreflex sensitivity and heart rate variability in systemic hypertension. Am J Cardiol 1999;83:885–9. https://doi.org/10.1016/s0002-9149(98)01067-4 732. Ganjehei L, Massumi A, Razavi M, Wilson JM. Orthostatic hypotension as a manifestation of vitamin B12 deficiency. Tex Heart Inst J 2012;39:722–3. 733. Shimbo D, Barrett Bowling C, Levitan EB, Deng L, Sim JJ, Huang L, et al. Short-term risk of serious fall injuries in older adults initiating and intensifying treatment with antihypertensive medication. Circ Cardiovasc Qual Outcomes 2016;9:222–9. https://doi.org/ 10.1161/circoutcomes.115.002524 734. Krediet CT, van Lieshout JJ, Bogert LW, Immink RV, Kim Y-S, Wieling W, et al. Leg crossing improves orthostatic tolerance in healthy subjects: a placebo-controlled crossover study. Am J Physiol Heart Circ Physiol 2006;291:H1768–72. https://doi.org/ 10.1152/ajpheart.00287.2006 735. Okamoto LE, Diedrich A, Baudenbacher FJ, Harder R, Whitfield JS, Iqbal F, et al. Efficacy of servo-controlled splanchnic venous compression in the treatment of orthostatic hypotension: a randomized comparison with midodrine. Hypertension 2016;68: 418–26. https://doi.org/10.1161/hypertensionaha.116.07199 736. Okamoto LE, Celedonio JE, Smith EC, Gamboa A, Shibao CA, Diedrich A, et al. Local passive heat for the treatment of hypertension in autonomic failure. J Am Heart Assoc 2021;10:e018979. https://doi.org/10.1161/jaha.120.018979 737. Buyken AE, von Eckardstein A, Schulte H, Cullen P, Assmann G. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study. Eur J Cardiovasc Prev Rehabil 2007;14:230–6. https://doi.org/10. 1097/HJR.0b013e3280142037 738. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993;328: 1676–85. https://doi.org/10.1056/nejm199306103282306 739. Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J 2023;44:4043–140. https://doi.org/10.1093/eurheartj/ehad192 740. Pylypchuk R, Wells S, Kerr A, Poppe K, Harwood M, Mehta S, et al. Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study. Lancet 2021;397:2264–74. https://doi.org/10.1016/s0140-6736(21) 00572-9 741. Danaei G, Fahimi S, Lu Y, Zhou B, Hajifathalian K, Di Cesare M, et al. Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis

ESC Guidelines                                                                                                                                                                                          4011

Downloaded from academic.oup.com/eurheartj/article/45/38/3912/7741010 by guest on 07 October 2026